<SEC-DOCUMENT>0001377739-22-000008.txt : 20220325
<SEC-HEADER>0001377739-22-000008.hdr.sgml : 20220325
<ACCEPTANCE-DATETIME>20220325163724
ACCESSION NUMBER:		0001377739-22-000008
CONFORMED SUBMISSION TYPE:	PX14A6N
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20220325
DATE AS OF CHANGE:		20220325
EFFECTIVENESS DATE:		20220325

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCA Healthcare, Inc.
		CENTRAL INDEX KEY:			0000860730
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				273865930
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6N
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-176949
		FILM NUMBER:		22771946

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLZ
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		6153449551

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLAZA
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA Holdings, Inc.
		DATE OF NAME CHANGE:	20101126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA INC/TN
		DATE OF NAME CHANGE:	20010627

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA THE HEALTHCARE CO
		DATE OF NAME CHANGE:	20010419

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOC Investment Group
		CENTRAL INDEX KEY:			0001377739
		IRS NUMBER:				203688367

	FILING VALUES:
		FORM TYPE:		PX14A6N

	BUSINESS ADDRESS:	
		STREET 1:		1900 L STREET NW
		STREET 2:		SUITE 900
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20036
		BUSINESS PHONE:		202 721 6060

	MAIL ADDRESS:	
		STREET 1:		1900 L STREET NW
		STREET 2:		SUITE 900
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CtW Investment Group
		DATE OF NAME CHANGE:	20061006
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6N
<SEQUENCE>1
<FILENAME>hca22letter.htm
<TEXT>

<HTML>
<HEAD>
   <TITLE>hca22letter.htm - Generated by SEC Publisher for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">



<P>&nbsp; <A name="page_1"></A></P>

<P style="TEXT-ALIGN: center; MARGIN: 0in" align=center><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman">SECURITIES &amp; EXCHANGE COMMISSION</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0in" align=center><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman">WASHINGTON, D.C.&nbsp;&nbsp; 20549</FONT></B></P>

<P style="TEXT-ALIGN: center; MARGIN: 0in" align=center><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman">NOTICE OF EXEMPT SOLICITATION (VOLUNTARY SUBMISSION)</FONT></B></P>

<P style="MARGIN: 0in"><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman"></FONT></B>&nbsp;</P>

<P style="MARGIN: 0in"><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman">NAME OF REGISTRANT:</FONT></B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman"> HCA Healthcare, Inc.&nbsp;&nbsp;&nbsp; </FONT></P>

<P style="MARGIN: 0in"><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman">NAME OF PERSON RELYING ON EXEMPTION:</FONT></B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman"> SOC Investment Group</FONT></P>

<P style="MARGIN: 0in"><B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman">ADDRESS OF PERSON RELYING ON EXEMPTION:</FONT></B><FONT lang=EN-US style="FONT-SIZE: 12pt" face="times new roman"> 1900 L Street, N.W., Suite 900, Washington, D.C. 20036</FONT></P>

<P style="MARGIN: 0in"><B><FONT lang=EN-US style="FONT-SIZE: 12pt" color=#1a1a1a face="times new roman">Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exchange Act of 1934:</FONT></B></P>

<P style="MARGIN: 0in"><B><FONT lang=EN-US style="FONT-SIZE: 12pt" color=#1a1a1a face="times new roman">_________________________________________________________________________________________________________________________________________________________________</FONT></B></P>

<P style="MARGIN: 0in"><STRONG><FONT color=#1a1a1a></FONT></STRONG>&nbsp;</P>

<a name="_bclPageBorder1"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<a name="_bclHeader1"></a><DIV>

<P style="MARGIN: 0in"><FONT lang=EN-US style="FONT-SIZE: 11pt" face=Calibri,sans-serif>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<IMG alt="Text&#10;&#10;Description automatically generated with medium confidence" src="x22032511260400.gif" width=282 height=66></FONT></P></DIV>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="FONT-SIZE: 11pt; LINE-HEIGHT: 107%" face=Calibri,sans-serif></FONT>&nbsp;</P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US style="FONT-SIZE: 12pt" face=Calibri,sans-serif>March 25, 2022</FONT></P><FONT style="FONT-SIZE: 12pt">

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>To HCA Healthcare, Inc. Shareholders:</FONT></P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>We urge you to vote FOR Proposals #4 and #5, stockholder proposals regarding political spending disclosure and lobbying disclosure, respectively, at HCA Healthcare, Inc. (HCA)&#8217;s annual meeting on April 21, 2022. These proposals ask HCA to issue reports detailing both direct spending in each category (i.e. campaign spending and lobbying expenses) as well as indirect spending via trade associations and other third-party entities which use dues payments to support electoral efforts or lobby, including &#8220;grassroots lobbying&#8221; efforts aimed at the public. Currently, the information HCA provides may not include contributions to ballot measures, does not disclose state-level lobbying expenses, excludes lobbying expenses under $50,000, and fails to acknowledge contributions to some third parties that are used for lobbying.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>1</SUP></FONT></P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>The SOC Investment Group, formerly known as CtW Investment Group, works with pension funds sponsored by unions affiliated with the Strategic Organizing Center, a coalition of four unions representing more than four million members, to enhance long term shareholder value through active ownership. These funds have over $250 billion in assets under management and are also substantial HCA shareholders.</FONT></P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>Over the past decade, disclosure of political spending and lobbying expenses have each become much more widespread among S&amp;P 500 companies: 60% of S&amp;P 500 companies disclose some or all of their electoral spending, and one third are disclosing payments to third-party groups such as trade associations and 501(c)(4) groups.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>2 </SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>HCA has clearly fallen behind in its peers, as it receives a 32.9% score on the CPA-Zicklin Index of Corporate Political Disclosure and Accountability, compared to an average of 56.6% for the health care industry.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>3 </SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif><SUP></SUP>Additionally, HCA&#8217;s failure to clearly disclose lobbying expenses &#8211; including the portion of contributions to third-parties that are used for lobbying &#8211; puts it behind leading firms such as AT&amp;T, Comcast, and Exxon.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>4 </SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>Shareholders need these disclosures in order to determine if corporate resources are being used in ways that align with their interests, or if the companies they invest in are accruing reputational and other risks through electoral and lobbying expenditures. </FONT></P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>While we support disclosure of political spending and lobbying across companies, the situation at HCA is particularly urgent, given mounting evidence that HCA is taking on substantial risk of adverse enforcement actions through its aggressive admissions practices, as described in a report published by the Service Employees International Union (SEIU) (available here)</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>5</SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>. This report demonstrates that HCA hospitals admit patients from their emergency departments at higher rates than other hospitals on</FONT></P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif></FONT>&nbsp;</P></FONT>

<HR align=left width="20%">



<P style="MARGIN: 0in 0in 8pt"></P>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="FONT-SIZE: 9pt; VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif><FONT style="FONT-SIZE: 11pt">1</FONT></FONT><FONT lang=EN-US style="FONT-SIZE: 11pt" face=Calibri,sans-serif> HCA Healthcare, Inc. Political Contributions Report, (https://hcahealthcare.com/util/documents/2022/2022-HCA-Healthcare-Political-Participation-Contributions-Breakdown-a.pdf )</FONT></P><FONT style="FONT-SIZE: 11pt">

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>2</FONT><FONT lang=EN-US face=Calibri,sans-serif> https://www.politicalaccountability.net/our-impact/#</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>3</FONT><FONT lang=EN-US face=Calibri,sans-serif> 2021 CPA-Zicklin Index of Corporate Political Disclosure and Accountability, pgs. 33, 50.</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>4</FONT><FONT lang=EN-US face=Calibri,sans-serif> </FONT><FONT lang=EN-US color=#0563c1 face=Calibri,sans-serif>https://about.att.com/csr/home/governance/political-engagement.html</FONT><FONT lang=EN-US color=black face=Calibri,sans-serif>&nbsp;; </FONT><FONT lang=EN-US color=#0563c1 face=Calibri,sans-serif>https://corporate.comcast.com/impact/values-integrity/integrity/activity</FONT><FONT lang=EN-US color=black face=Calibri,sans-serif>&nbsp;;</FONT><FONT lang=EN-US face=Calibri,sans-serif> https://corporate.exxonmobil.com/-/media/Global/Files/policy/lobbying/ExxonMobil_2020-Lobbying-Report.pdf</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>5</FONT><FONT lang=EN-US face=Calibri,sans-serif> https://hcavsamerica.org/wp-content/uploads/2022/02/SEIU_Investigative_Report_FINAL-1.pdf</FONT></P>

<P style="MARGIN: 0in">
<IMG src="x22032511260401.gif" width=601 height=3>&nbsp;</P>

<P style="MARGIN: 0in">
<IMG src="x22032511260402.gif" width=175 align=left height=27>
<IMG id=Picture_x0020_272 alt=shape src="x22032511260403.gif" width=212 height=29>
<IMG src="x22032511260404.gif" width=283 height=39></P></FONT>

<HR align=left SIZE=1 width="33%">



<DIV id=ftn1>

<P style="MARGIN: 0in">&nbsp;</P>

<P style="MARGIN: 0in">&nbsp;</P></DIV></DIV>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always">&nbsp;</DIV>

&nbsp; <A name="page_2"></A><FONT style="FONT-SIZE: 12pt">

<a name="_bclPageBorder2"></a><DIV style="PADDING-LEFT: 0%; PADDING-RIGHT: 0%">

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>average nationally,</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>6</SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>at higher rates than the average of other hospitals on a state-by-state basis,</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>7</SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>and at higher rates than expected based on acuity and geography.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>8 </SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>Moreover, as this report details, HCA executives have clearly articulated their desire to boost admissions in order to drive higher revenue and net income.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>9 </SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif><SUP></SUP>The report estimates that these aggressive admissions practices may have increased Medicare payments alone to HCA by $1.8 billion from 2008 through 2019.</FONT><FONT lang=EN-US face=calibri,sans-serif><SUP>10 </SUP></FONT><FONT lang=EN-US face=Calibri,sans-serif>Because both state and federal regulators are responsible for overseeing payments to health care providers, both campaign contributions and lobbying spending create the risk that HCA may be seen to be attempting to forestall the enforcement of the rules surrounding such payments. Additionally, high levels of campaign and lobbying spending may incline HCA executives and directors to believe that regulators will take a sympathetic view of the company&#8217;s operations and dissuade them from needed efforts to ensure that aggressive admissions practices do not cross the line into unlawful activity. Finally, like any business that depends substantially on government spending, overtly partisan stances in elections and lobbying activity may put the company's reputation at risk. </FONT></P>

<P style="MARGIN-BOTTOM: 2pt"><FONT lang=EN-US face=Calibri,sans-serif>In light of these risks, as well as the risks of misalignment inherent in undisclosed corporate activity, we urge you to vote For Proposals #4 and #5 at HCA Healthcare, Inc.&#8217;s annual meeting on April 22, 2022. For further information, please contact our Research Director Richard Clayton at&nbsp;<FONT style="FONT-SIZE: 12pt" face=Calibri>rclayton@socinvestmentgroup.com.</FONT></FONT></P>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="LINE-HEIGHT: 107%" face=Calibri,sans-serif></FONT>&nbsp;</P>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="LINE-HEIGHT: 107%" face=Calibri,sans-serif>Sincerely,</FONT></P>

<P style="MARGIN: 0in 0in 8pt">
<IMG id=Picture1 border=0 src="x22032511260500.gif" width=153 height=46></P>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="LINE-HEIGHT: 107%" face=Calibri,sans-serif>Dieter Waizenegger Executive Director</FONT></P>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="LINE-HEIGHT: 107%" face=Calibri,sans-serif></FONT>&nbsp;</P>

<P style="TEXT-ALIGN: center; MARGIN: 0in" align=center><FONT lang=EN-US style="LINE-HEIGHT: normal" face=calibri-bold>This is not a solicitation of authority to vote your proxy. Please DO NOT send us your proxy card as it will not be accepted</FONT></P>

<P style="MARGIN: 0in 0in 8pt"><FONT lang=EN-US style="LINE-HEIGHT: 107%" face=Calibri,sans-serif></FONT>&nbsp;</P>

<HR align=left SIZE=1 width="33%">



<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>6</FONT><FONT lang=EN-US face=Calibri,sans-serif> SEIU, HCA: Higher Healthcare Costs for America (2022), pg. 6.</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>7</FONT><FONT lang=EN-US face=Calibri,sans-serif> Ibid., pg. 7.</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>8</FONT><FONT lang=EN-US face=Calibri,sans-serif> Ibid., pg. 9.</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>9</FONT><FONT lang=EN-US face=Calibri,sans-serif> Ibid., pgs. 15-19.</FONT></P>

<P style="MARGIN: 0in"><FONT lang=EN-US style="VERTICAL-ALIGN: super; LINE-HEIGHT: 107%" face=calibri,sans-serif>10</FONT><FONT lang=EN-US face=Calibri,sans-serif> Ibid., pgs. 8-9.</FONT></P>

<P style="MARGIN: 0in"><FONT face=Calibri></FONT>&nbsp;</P></DIV></FONT>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>x22032511260400.gif
<TEXT>
begin 644 x22032511260400.gif
M1TE&.#=A80%3 /\  +G1TH>OLWZNL?_Z^O^ <=;<W.?J[+_'R?O]_?^.@J^Y
MO/Z9CV9\?]G?W_^NI?]0//_+QK#*S/]<2HR<GF^"AG^0D__7TO^CFO^)?/^V
MKH^WN(:XO/_Q[[O$QO_=VO_T\_],-I_!P^ON[IJ_PN'GY_^#=_^!=(*NL,_?
MX-CEY<G;W/Z1AJC&R/_&P._R\H.UN("MKWZ0DY:ZO7>+CG.'BO^IG_]T9(BS
MMGZKK69\?YVKK%UW>J&OL/_(P/^@E?Z0A/_2S?Z+?_]*-=/BXVI_@HV>H)VK
MK/_7TWZJK-[BX_^[L_[,QOZ&>.+L[%AQ=/_-Q__@WEMU>/ZAEZ'!PYK P\?/
MT<+7V/_IY_]N7Z_-S]KFY[;0T9&@HN_T]/]F5/]A3Z?%Q]K@X)*XNIN^P/]6
M0XFVN/W]_N?O[]'7V?_4T?^HGY.XNV-Z?,'6V*S*RI:DIEUU>/Z8CO]=2Y2C
MI;3.T;#,S:.OLOZ(>_][;+6_P7NIJ_^SJZ'#Q.WP\='@X8.4EZ>SM?]+-IV_
MP?]K6X^VMX*SMMOAXO]61/CY^>/M[86WNK+-SO]B4+O$Q7RKKE5M</_(PL7,
MS?_IY__DXLC;W/]Q8/_#O/]G5Y"VN>+FYIN]O\O1TZG'R?_ NEMU>(2VN?]V
M9_^3B/[+QK&\O>#JZ\/7V/;X^5QV>8&RM:FTMG>+C.7N[OZ&>:NWN</,SJNW
MN/Z+?<O3T[2]O[W3U/_:UU=P<\;9VO[T\\W3U/Z@E?_7T^+FYO_2SHF^P9+*
MSO^PIYW P<_4U5AP<\O1T_Z6BUQU>8>[OO7V]O/V]O^=D=[BX\7,S9[ PJFT
MM\78VH67F(J_PYV_PE9N<<O=WL7-SJK'R9Z]P/^GGJG&R/^HGOY&,OY&,IR]
MO_7V]L7.S_Z>DYW#Q)3,SX27FOZ1A?Y&,O[0R_Y&,EEP<_Z?EOZ0A%IP<_Z.
M@?ZAEI#&ROZ.@:>SM<O3T\O3U/_9UGFHJ_Y&,OZ:C;[4U?^=D?Y&,GNGJEAP
M<__DX/^7BZ:TM?Z$>/___R'Y! $  /\ +     !A 5,   C_ /\)'$B0( <+
M&?CAP3)H$!90ZRYTDO>AH,6+&/\=S!#*!B,R0K2!.#2(@(].4 9D7&GQ"I!?
M"2I]>:!-Y*%+H%;L <*!I<^?0(,*'4JTJ-&C2),J);CO%Z@'0D $$D*UJI!
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M@WF =@@;G9Q;)&[*@3J0C6Z4D &,L_ RFQR@OO\P@!M(@))-"%FV6[AP,.K
MARFD.<V< )LW+-:;+&QQ %JH@W91@01-3$.7&ZT5)30QCP @P1INJ@@G>HPX
B;"@Q$IO5RP=HK#LWY"I,G)!QQBCM03JP@ \A4/,4 @( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>x22032511260401.gif
<TEXT>
begin 644 x22032511260401.gif
M1TE&.#=A60(# /H  .]&-O>AF/O1S?SGY?_^_?[^_O___P   "'Y! $   8
M+     !9 @,   -7"+K<_C#*2:N]..O-N_]@*(YD:9YHJC(!(;QP+,]T;=]X
MKN]\[__ H'!(+!J/R*1RR6PZG[%!P4"M6J_8K';+[7J_X+!X3"Z;S^BT>LUN
+N]_PN'Q.QR8  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>x22032511260402.gif
<TEXT>
begin 644 x22032511260402.gif
M1TE&.#=AKP ; /T  ",?(#0L+C(L+T Y.D Z/3\Y/T]*2$]'2D]+2TQ*3%Y5
M55Q56%Q865A46VIC8VAE96AE9VAC:79N;G=P<'=P<G!N='9R='-P=71P=H1]
M?8!^@8!]@I"+B9")BY",C(R+CIV6E9>6G::EI;J[KJZ[N;V[O-/2RLG1T=/)
MTM[=U^GDY.3DZ/3Q\?'Q]/___P
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CUFCCC3CFJ...//;HXX] !BGDD$06:>212":IY)),%A$$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>x22032511260403.gif
<TEXT>
begin 644 x22032511260403.gif
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M_(*2U%(OC[2*7(T<PK^(0$5'1%*,A"@%!-)1K198(!?^^&1AB/;(?27RE%B
M 00:Q*'>) !L,<@&]#KER'7,K BF<F7-),0I0_;28#A#I3"Q()GI5"EXES.F
M:F"@ >CU+$C'Q.34AJ=&Y"D/<\4;IC:M@,$IB'";X)2?!Y;W!'W8)9SH3*<Z
BU\G.=KKSG?",ISSG2<]ZVO.>^,RG/O?)SW[Z\Y_Z"P( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>x22032511260404.gif
<TEXT>
begin 644 x22032511260404.gif
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M_(*2U%(OC[2*7(T<PK^(0$5'1%*,A"@%!-)1K198(!?^^&1AB/;(?27RE%B
M 00:Q*'>) !L,<@&]#KER'7,K BF<F7-),0I0_;28#A#I3"Q()GI5"EXES.F
M:F"@ >CU+$C'Q.34AJ=&Y"D/<\4;IC:M@,$IB'";X)2?!Y;W!'W8)9SH3*<Z
BU\G.=KKSG?",ISSG2<]ZVO.>^,RG/O?)SW[Z\Y_Z"P( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>x22032511260500.gif
<TEXT>
begin 644 x22032511260500.gif
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M%H@#66%%!5UNE)HWBG!"SB"@6?GEG@2%*68.MBPR2QV+3$% &.(T98MZZM'
MAA$+H1=<&ZG5Q)! -,B@!0E^_&+&@D L6B".?#4XT' ;.?C4C5#54@X)BXS_
M$8(DEA#YTFU,W?8;1GX.J,:!)Z0"! BD#)'+%Z%1HH(*^R#(S"GHJ%#!0YQ(
MI%!M0%3 9!1F:*$ G!92(FYC J%3SDNVL"-+:26\08,*%75)G%,%\M1C:(LM
MR5,M@ZR1 20WB,'(&JF@,18Z7U3PA3AO;59(+4! K&V/O;Y4$2P)<%+($&7L
M -H53HSR5@XJF$& 'J#!YHTORWQ1B(<)Y7*$"6"8 <M>$9%K4(CO,64+;$B@
M<@8JW:R$'W $U;M3:K:JBM,8VQB"S", 1%!'(+J4L4(:0Q0B3B$Y( 1$& =%
MG$. %(>$'D4_I#$V,AD P'!SG/SGH3( ^%4!$7E<_Q#+$;GD:@LZ8$!"PQ%R
M? :$+&9PPF%$ <(D4!AFH'%.'6@DLHC2P!D=U;U3I<$*)[GD0D(NE%< P#)3
M]*&+'0&6\T53:E2@A0.6*%/I%7XR10(Z!)B@3"YM#/ #$+F8L4@:Q[P 1R<>
MDE !)68(\@,GD3Q#PLMJ%&*.&9Y$T4:9H+8AB"K'*&(C10FEA@X-/_1BQC,;
M].C>0&W8@M5_4OVBP8Y/L4 0CN"$A)$ 634Q P"X88(X) $8%1B%.:YPB4UL
MX@11\,$05,([D$#$0TL(A!G"< 5CR$\+UMC##'SP"T' HV3H08<>X* %+90
M +4PX#YRT0!(F 00L C#%__, (9O$$$+@R# >\K2/C.TP@MF<,,K3@' YM"D
M0;=XQ><4:(4JW6\G!'#&H6!#NQ>1K0YK^(8)=B +6YPB"R$X B?XP(<E]:HO
MBP@",CSTB&,X0!%B\(0DE+,%7R!()<K8@ [,H I  &$?R*H $Z[P@Q\PB1@6
M H(R3#$ @1  %B00!XIJURT6=,,,0_#"(G1$+\HTI3J#4(5R>B(],SS"4\-Q
MFDA(H(M7T,86E)B=&L+@!'/4 D&U ,,G>/ '+=   M[(A3G,D0MR]:HNW-@
M#1#$!588H!6_4$,YI%6!'XR (35IQBK,D(8; * 0*DB(!,[0 !90@1.S< 0Z
M4A/_!4_4PAQML(.)6@*:+UPA$%/8X *H>!6"N%(-+L%$'&CPE+?@IUHKN=1.
M3L$ !R@C A/(00540 EV($MZ$F@##7"Q@B?  !]G$,85CL"86AS!3[;X A
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M?]I\!\1G(C-"=A&*#4-2LSM:7&4+O< /5= '/G ")^ #&] #?_ +DA8QJ;$
MF=!I\N$Y'J&S$+%PA6@K!"P2\^L1EB(@&:5+!<=G'(0>2)<KXNAK_,<S0, .
M[8,>N/(>!W<0\)$K/5,A,,%G;9 &AO 'GA"]A= &%P -(, 7'Z8M(, *3)E+
MSLHGE9%1Z.G$.C$;E%(]_9 !R, 7E)"Y9' 'X/\Y@14  9D80^FIQX%!')/R
MNE&1'C;!#7-P V,1*HYE!DNP#KS7&(6 #ER0 4KA&WY\$14CR7_,P&@QGV8
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</=JD7=JF?=JHG=JJ7=I#< +(L-JP_=D1$!  .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
